Metraipolis › archive › dc_98da7ffac7f2
Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer — Europe PMC PMID:41898213
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41898213
- DOI
- 10.3390/biomedicines14030566
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T09:44:07.436Z
- SHA-256 of the archived text
0f8638f596505b6efc86b2884630b1fd181ecf198843bea9bfa3fd4b98f2cce0- Stable URL of this page
https://metraipolis.com/documento/dc_98da7ffac7f2
How to cite
Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer — Europe PMC PMID:41898213 — Europe PMC (en), https://europepmc.org/article/MED/41898213 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98da7ffac7f2 (Metraipolis archive dc_98da7ffac7f2, sha256 0f8638f596505b6efc86b2884630b1fd181ecf198843bea9bfa3fd4b98f2cce0)
BibTeX
@misc{dc98da7ffac7f2,
title = {Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer — Europe PMC PMID:41898213},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41898213},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98da7ffac7f2; sha256 0f8638f596505b6efc86b2884630b1fd181ecf198843bea9bfa3fd4b98f2cce0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898213. Agents can read the archived copy with the MCP tool read_document.